PM.20.036 – RiboMetProsCan – targeting ribosomal RNA methylation to combat prostate cancer
Route: Personalised medicine: the individual at the centre
cluster question: 085 Every tumour is different, so how can we come to understand cancer well enough to develop a treatment for each and every type?
Cancer is the leading cause of death in the Netherlands. Among all cancer types, prostate cancer is the most common […]
View the initiative
PM.20.020 – Defining the immunological landscape to develop personalized medicine strategies across disease & age
Route: Personalised medicine: the individual at the centre
cluster question: 095 How can we personalise health care, for example by using biomarkers?
The striking patient-to-patient heterogeneity of chronic immune-mediated inflammatory disorders (IMIDs) such as Crohn’s disease, ulcerative colitis, rheumatoid arthritis, and atopic […]
View the initiative
PM.20.021 – Transitioning to a personalised breast cancer screening and prevention paradigm: delivering the final pieces of the implementation puzzle
Route: Personalised medicine: the individual at the centre
cluster question: 095 How can we personalise health care, for example by using biomarkers?
Implementation of risk stratification, biomarkers, and artificial intelligence in breast cancer screening is already at the forefront of politicians’ and […]
View the initiative
PM.20.024 – Sphingolipids in life and disease: in science, clinic and society
Route: Personalised medicine: the individual at the centre
cluster question: 083 How do neurological, psychiatric, and mental disorders arise, and how can we prevent, mitigate, or cure them?
Lipids are essential for life and abnormalities in their production and/or breakdown may reflect ongoing diseases such as in the […]
View the initiative